139 Double-dose gadolinium SRS planning MRI reduces repeat treatment for brain metastases
Double‑dose gadolinium contrast for stereotactic radiosurgery (SRS) planning MRI can increase detection of brain metastases, but its clinical benefit remains uncertain. One hypothesised advantage is reduced need for repeat SRS by treating small lesions earlier. We compared outcomes in patients planned with double...